Meet us at Food ingredients Europe
Meet us at Food ingredients Europe 29 November 2022 – 2 min read We are excited to be exhibiting for the first time at Food… Read More »Meet us at Food ingredients Europe
Home »
Articles
Nouri and AB-BIOTICS launch preventative probiotic solution for dysbiosis related risks in pregnancy
To offer a preventive, natural solution to Filipinos in risk of high cholesterol, Pharex and AB-BIOTICS have recently launched Biome Lipidec.
AB-BIOTICS attending events and congresses in Asia
We are excited to be attending not one but three events in Asia during the remainder of this year. As part of Kaneka Probiotics, we’re always looking to connect with our customers and partners in the region.
What is dysbiosis and what are its consequences?
For World Microbiome Day, let’s talk about gut dysbiosis and its detrimental impact in human health.
AB-BIOTICS’ AB21® and LipiGO®, winners of the NutraIngredients Awards
We are thrilled to announce that our two finalists, AB21® and LipiGO®, have both taken home the crown in their respective categories for this year’s NutraIngredients Awards
AB-KOLICARE™ probiotic strains show remarkable properties for infant gastrointestinal disorders (FGIDs)
Frontiers has published the latest clinical data of AB-KOLICARE™, that shows quite promising results on infant colic. This probiotic formulation leads AB-BIOTICS pediatric line, containing two bacteria strains with a battery of benefits for babies.
AB21 spreads presence in Asia with AceBiome
A newly published clinical trial in Gut Microbes – a top journal reporting the latest science in microbiota – has confirmed that Kaneka Group / AB-Biotics’ AB21 probiotic formulation exhibits significant positive effects in COVID-19 outpatients.
AB21 demonstrates benefit in COVID-19 outpatients
A newly published clinical trial in Gut Microbes – a top journal reporting the latest science in microbiota – has confirmed that Kaneka Group / AB-Biotics’ AB21 probiotic formulation exhibits significant positive effects in COVID-19 outpatients.
AB-LIFE, first probiotic approved in Brazil for high cholesterol
AB-LIFE probiotic formulation has recently been approved by the Brazilian Health Regulatory Agency (Agência Nacional de Vigilância Sanitária, Anvisa) as a safe and efficient food supplement to help reduce cholesterol levels.
New outstanding AB-KOLICARE™ clinical data published in Frontiers
Frontiers has published the latest clinical data of AB-KOLICARE™, that shows quite promising results on infant colic. This probiotic formulation leads AB-BIOTICS pediatric line, containing two bacteria strains with a battery of benefits for babies.
